Na Rae Lee

Na Rae Lee

Auto-generated profile, based on publicly available information

Na Rae Lee

Division of Healthcare Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2012 in BMC Neurology
Verified
Journal Article
Open access
PDF file
JHJin Seub Hwang
Jin Seub Hwang
MHMin Kyung Hyun
Min Kyung Hyun
HLHyun Joo Lee
Hyun Joo Lee
JCJi Eun Choi
Ji Eun Choi
JKJong Hee Kim
Jong Hee Kim
ELEnJu Lee
EnJu Lee
Background: To compare the effects of endovascular coiling and neurosurgical clipping in patients with unruptured intracranial aneurysm. Methods: Sixteen electronic databases were searched for articles published between 1950 and July 2010 to compare clinical outcomes of clipping and coiling. Researchers reviewed all searched articles and extracted data independently. The quality of studies and evidence were evaluated using MINORS and GRADEprofiler, respectively. The odds ratio (OR) was calculated using the inverse variance meta-analysis method for each study outcome. To assess heterogeneity of ORs across cohorts, Cochran’s Q statistic and I2 were used. Results: Of 4160 studies, 24 were identified (n = 31865). Clipping resulted in significantly higher disability using the Glasgow Outcome Scale (OR, 2.38; 95% CI, 1.33–4.26) and Modified Rankin Scale (OR, 2.83; 95% CI, 1.42–5.63) when compared with coiling. ORs for complications were also higher with clipping (ORs for neurological and cardiac complications were 1.94 with a 95% confidence interval [CI] of 1.09–3.47 and 2.51 with a 95% CI of 1.15–5.50). Clipping resulted in significantly greater disability in the short term (≤6 m)(OR on the Glasgow Outcome Scale, 2.72; 95% CI, 1.16–6.34), but not in the long term (>6 m)(OR for Glasgow Outcome Scale, 2.12; 95% CI, 0.93–4.84). Conclusions: Coiling was a better procedure for treatment of unruptured intracranial aneurysm in terms of disability, complications, especially in the short term. Because of the limitations of the reviewed studies, further studies are required to support the present results.

1 January 2022 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
YJYan Jin
Yan Jin
JJJae Hung Jung
Jae Hung Jung
WHWoong Kyu Han
Woong Kyu Han
EHEu Chang Hwang
Eu Chang Hwang
YNYoonmi Nho
Yoonmi Nho
SYSu-Yeon Yu
Su-Yeon Yu
Jin Y, et al. Investig Clin Urol. 2022 May;63(3):251-261. https://doi.org/10.4111/icu.20210429

1 March 2019 in Prostate International
Verified
Journal Article
Open access
JYJi Eun Yun
Ji Eun Yun
NLNa Rae Lee
Na Rae Lee
CKCheol Kwak
Cheol Kwak
KRKoon Ho Rha
Koon Ho Rha
SSSeong Il Seo
Seong Il Seo
SLSeon Heui Lee
Seon Heui Lee
This study compared the surgical, functional, and oncologic outcomes of robot-assisted laparoscopic radical prostatectomy (RALP), laparoscopic radical prostatectomy (LRP), and retropubic radical prostatectomy (RRP) in Korean men. The study population included 864 patients who underwent radical prostatectomy for prostate cancer in the departments of urology of five tertiary hospitals between 2010 and 2011. RALP, LRP, and RRP perioperative, oncological, and functional outcomes as well as complications were assessed. Medical cost data were analyzed for 682 of 864 patients. No significant differences were found among the three groups regarding the length of stay, biochemical recurrence, complications, and metastasis. The RALP group had a significantly higher rate of pelvic lymph node dissection (64.6% vs. 35.3% or 53.3%, P value <0.0001) and bilateral nerve-sparing procedures (15.7% vs. 10.0% or 8.9%, P value <0.0001) and less blood loss (median 250 mL vs. 300 mL or 700 mL, P value <0.0001) than the LRP and RRP groups. The 12-month continence recovery rate was higher in the RALP group (92.1%) than in the LRP (86.5%) and RRP (84.4%) groups (P value <0.0001). Medical costs for RALP were approximately twofold to threefold higher than those for LRP or RRP. Our findings suggest that surgical and functional outcomes are better with robot-assisted surgery than with laparoscopic or open surgery in terms of estimated blood loss and urinary continence; however, no differences were found among groups in terms of biochemical recurrence and the rate of complications.

3 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WLWoojin Lim
Woojin Lim
SMSungji Moon
Sungji Moon
NLNa Rae Lee
Na Rae Lee
HSHo Gyun Shin
Ho Gyun Shin
SYSu-Yeon Yu
Su-Yeon Yu
Sue K. ParkSue K. Park
Sue K. Park
We aimed to summarize the cancer risk among patients with indication of group I pharmaceuticals as stated in monographs presented by the International Agency for Research on Cancer working groups. Following the PRISMA guidelines, a comprehensive literature search was conducted using the PubMed database. Pharmaceuticals with few studies on cancer risk were identified in systematic reviews; those with two or more studies were subjected to meta-analysis. For the meta-analysis, a random-effects model was used to calculate the summary relative risks (SRRs) and 95% confidence intervals (95% CIs). Heterogeneity across studies was presented using the Higgins I square value from Cochran’s Q test. Among the 12 group I pharmaceuticals selected, three involved a single study [etoposide, thiotepa, and mustargen + oncovin + procarbazine + prednisone (MOPP)], seven had two or more studies [busulfan, cyclosporine, azathioprine, cyclophosphamide, methoxsalen + ultraviolet (UV) radiation therapy, melphalan, and chlorambucil], and two did not have any studies [etoposide + bleomycin + cisplatin and treosulfan]. Cyclosporine and azathioprine reported increased skin cancer risk (SRR = 1.32, 95% CI 1.07–1.62; SRR = 1.56, 95% CI 1.25–1.93) compared to non-use. Cyclophosphamide increased bladder and hematologic cancer risk (SRR = 2.87, 95% CI 1.32–6.23; SRR = 2.43, 95% CI 1.65–3.58). Busulfan increased hematologic cancer risk (SRR = 6.71, 95% CI 2.49–18.08); melphalan was associated with hematologic cancer (SRR = 4.43, 95% CI 1.30–15.15). In the systematic review, methoxsalen + UV and MOPP were associated with an increased risk of skin and lung cancer, respectively. Our results can enhance persistent surveillance of group I pharmaceutical use, establish novel clinical strategies for patients with indications, and provide evidence for re-categorizing current group I pharmaceuticals into other groups.

1 January 2026 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
JYJi Eun Yun
Ji Eun Yun
KLKwang Suk Lee
Kwang Suk Lee
HLHakmin Lee
Hakmin Lee
SLSang Hyub Lee
Sang Hyub Lee
JJJae Hung Jung
Jae Hung Jung
SYSu-Yeon Yu
Su-Yeon Yu
Yun JE, et al. Investig Clin Urol. 2026 Jan;67(1):32-42. https://doi.org/10.4111/icu.20250299

28 February 2025 in Restorative Dentistry & Endodontics
Verified
Journal Article
Open access
MKMin Jung Ko
Min Jung Ko
JPJu Hyun Park
Ju Hyun Park
NLNa Rae Lee
Na Rae Lee
JYJoon-Ho Yoon
Joon-Ho Yoon
YKYoung-Taek Kim
Young-Taek Kim
SCSin-Yeon Cho
Sin-Yeon Cho
Objectives: While the success criteria of endodontic microsurgery (EMS) have been consistently defined and widely accepted, the success criteria of dental implants are outdated and focus only on the implant fixture and surrounding bone. This study aimed to evaluate the outcomes of EMS and single implants (SIs) with explicit criteria.Methods: We searched for articles published from January 2010 to February 2022 and discussed them and consulted with a clinical advisory committee composed of four dental specialists and one epidemiologist during article selection and data extraction.Results: Twenty-two EMS studies and six SI studies were included in the meta-analysis. Teeth treated using EMS had a pooled success rate of 89% (90% at <5-year follow-up and 80% at ≥5-year follow-up) and the pooled success rate of SI was 78%.Conclusions: The success rates of the two procedures with similar follow-up periods were comparable. Subgroup analysis found no other variable that significantly influenced study heterogeneity. Considering the treatment sequence and the similar success rates, it would be advantageous to consider EMS, rather than implants, first in a situation where both procedures are applicable.